Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Anacor Pharmaceuticals Names New VP and CFO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Anacor Pharmaceuticals Names New VP and CFO

Graeme Bell brings more than 20 years expertise in global finance, M&A and business development

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Anacor Pharmaceuticals has named Graeme Bell as its new executive vice president and chief financial officer. Mr. Bell has more than 20 years of global financial experience in the pharmaceutical industry, and will succeed Geoffrey Parker as of June 1, 2015. Mr. Parker will remain with Anacor as a consultant to support the transition. Mr. Bell joins Anacor from Merck where he served since 2010 as its vice president, country chief financial officer, U.S. human health, responsible for the financial oversight and support of Merck’s U.S. pharmaceutical and vaccine business.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters